Amgen battles for EPO in Congress.
Chahine
K
K
D001709:Biotechnology / Q000331:legislation & jurisprudence*; D004921:Erythropoietin / Q000235:genetics*; D006801:Humans; D007880:Legislation, Drug; D010330:Patents as Topic; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin